You are another champ I read here btw. One thing I learned about is that medical seems to be pretty profitable. I didn't have time yet to compare the current and growth rates between CGC and ACB. ACB purposely didn't sell all their product into recreational because of their obligation to medical, and the fact its more profitable.... I'm not sure if its more profitable than the pre rolls, gelcaps etc, but it sounded like it.. and I have not had time to research it. I'm also curious if CGC was able to give timelines for how many tons of product will be coming into the market, instead of just a blanket we have more coming. The ACB CC was only hosted for 24hrs and I'm hoping its somewhere around on the internet, as it had a wealth of information we can use to see where CGC and ACB stand against eachother. I just remember that my jaw dropped when they stated how much they will be able to product, and I really want to compare that with CGC (I have a day job)... I currently believe the most money is in medical, then its anything but dried cannabis (processed like pre rolls is more for example), and then the dry.
Also, I'm interested in knowing if CGC is also actively lobbying insurance companies. Germany is waaaaaaaay ahead than canada on this front(medical insurance coverage) (at least my understanding). I want to know details of CGC and ACB in Germany, as I want to validate what I herad on ACB's investor meeting they had over their a week or so ago, saying others have not even broken ground...
ok.. off to my day job.
Market Data 
Markets 
AI
